QQ客服 官方微博 反馈留言

	The efficiency and safety of trastuzumab and lapatinib added to neoadjuvant chemotherapy in Her2-positive breast cancer patients: a randomized meta-analysis
	Chen, Zhe-Ling; Shen, Yan-Wei; Li, Shu-Ting; Li, Chun-Li; Zhang, Ling-Xiao; Yang, Jiao; Lv, Meng; Lin, Ya-Yun; Wang, Xin; Yang, Jin
刊名	ONCOTARGETS AND THERAPY
	2016
卷号	9期号:[db:dc_citation_issue]页码:3233-3247
关键词	breast cancer lapatinib trastuzumab human epidermal growth factor receptor neoadjuvant pathologically complete response
ISSN号	1178-6930
DOI	[db:dc_identifier_doi]
URL标识	查看原文
WOS记录号	[DB:DC_IDENTIFIER_WOSID]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3215774
专题	西安交通大学
推荐引用方式 GB/T 7714	Chen, Zhe-Ling,Shen, Yan-Wei,Li, Shu-Ting,et al. The efficiency and safety of trastuzumab and lapatinib added to neoadjuvant chemotherapy in Her2-positive breast cancer patients: a randomized meta-analysis[J]. ONCOTARGETS AND THERAPY,2016,9([db:dc_citation_issue]):3233-3247.
APA	Chen, Zhe-Ling.,Shen, Yan-Wei.,Li, Shu-Ting.,Li, Chun-Li.,Zhang, Ling-Xiao.,...&Yang, Jin.(2016).The efficiency and safety of trastuzumab and lapatinib added to neoadjuvant chemotherapy in Her2-positive breast cancer patients: a randomized meta-analysis.ONCOTARGETS AND THERAPY,9([db:dc_citation_issue]),3233-3247.
MLA	Chen, Zhe-Ling,et al."The efficiency and safety of trastuzumab and lapatinib added to neoadjuvant chemotherapy in Her2-positive breast cancer patients: a randomized meta-analysis".ONCOTARGETS AND THERAPY 9.[db:dc_citation_issue](2016):3233-3247.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。